The editors of JCI and JCI Insight are revisiting our editorial processes in light of the strain that the COVID-19 pandemic places on the worldwide scientific community. Here, we discuss adjustments to our decision framework in light of restrictions placed on laboratory working conditions for many of our authors.
Rexford S. Ahima, Sarah Jackson, Arturo Casadevall, Gregg L. Semenza, Gordon Tomaselli, Kathleen L. Collins, Andrew P. Lieberman, Donna M. Martin, Pavan Reddy
Title and authors | Publication | Year |
---|---|---|
Ayekoo - Well done!
Rex Ahima |
Journal of Clinical Investigation | 2022 |
Mortality in children with cancer and SARS-CoV-2 in Latin America: A systematic review
Dorantes-Acosta E, Ávila-Montiel D, Domínguez Rojas J, Parra-Nigañez P, Velasco-Hidalgo L, Arias S, Gutiérrez-Rivera L, Juárez-Villegas L, Márquez-González H |
Frontiers in Pediatrics | 2022 |
Resultados en la práctica asistencial y coste marginal del tratamiento con tocilizumab en pacientes COVID-19.
Garcia-Molina A, Alos-Almiñana M |
Farmacia Hospitalaria | 2022 |
Publication speed in pharmacy practice journals: A comparative analysis
AM Mendes, FS Tonin, FF Mainka, R Pontarolo, F Fernandez-Llimos, T Mathes |
PloS one | 2021 |
The Journal of Clinical Investigation in the time of COVID-19
A Casadevall, S Jackson, GL Semenza, GF Tomaselli, RS Ahima |
Journal of Clinical Investigation | 2021 |
A year at the helm
KL Collins |
JCI Insight | 2020 |
Scientific Publications During the COVID-19 Pandemic
AC Sepúlveda-Vildósola, JM Mejía-Aranguré, C Barrera-Cruz, NA Fuentes-Morales, C Rodriguez-Zeron |
Archives of Medical Research | 2020 |
How blood from coronavirus survivors might save lives
A Maxmen |
Nature | 2020 |